Advertisements



Pulmatrix announces publication of data from Phase 1 study of PUR0200

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Cytokinetics announces data from reldesemtiv Phase 2 clinical study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 18th, 2018

Cytokinetics announces data from Phase 2 clinical study of Reldesemtiv in SMA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 17th, 2018

Agios Pharmaceuticals announces new data from ivosidenib Phase 1 study at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Dova Pharmaceuticals announces publication of Doptelet Phase 3 data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Roche (RHHBY) Announces Positive Data on Hemophilia Drug

Roche (RHHBY) announces positive data from two phase III studies on hemophilia drug Hemlibra which has further strengthened its hemophilia portfolio. Roche RHHBY announced full results from the phase III study, HAVEN 3, evaluating haemo.....»»

Category: dealsSource: nytMay 21st, 2018

Teva reports publication of Phase III HALO study data in JAMA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2018

Endocyte announces publication of Phase 2 data from 177Lu-PSMA-617 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 9th, 2018

The Medicines Co. announces inclisiran data from ORION-1 Phase II study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 7th, 2018

Intercept Reports Phase III Sub-Study Liver Biopsy Data

Intercept (ICPT) announces data from the POISE biopsy sub-study which showed that treatment with obeticholic acid leads to the reversal or stabilization of fibrosis/cirrhosis in patien.....»»

Category: worldSource: nytApr 16th, 2018

NewLink announces data from Phase 1 study of Indoximod in combo therapies

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 15th, 2018

ConforMIS announces data from study of iTotal CR Knee Replacement Systems

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall4 hr. 48 min. ago

Progenics presents data from 1404 Phase 2 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall4 hr. 48 min. ago

Pulmatrix announces "positive" results from Phase 1/1b trial of Pulmazole

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall4 hr. 48 min. ago

BeyondSpring presents "positive" data drom Phase 2 portion of Study 105

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall4 hr. 48 min. ago

Ironwood announced Praliciguat phase IIa study data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 23rd, 2018

Anika Reports Top Line Data from CINGAL Study, Shares Slump

Anika Therapeutics' (ANIK) shares declined 37%, after the company reported disappointing data from its phase III Cingal 16-02 study in treating patients with osteoarthritis (OA) in the knee. Sha.....»»

Category: smallbizSource: nytJun 21st, 2018

Novo Nordisk"s (NVO) Oral Ozempic Positive in Diabetes Study

Novo Nordisk (NVO) announces positive headline results of two phase III studies PIONEER oral formulation of Ozempic (semaglutide) as a treatment for adults with type II diabetes. Novo Nordisk NVO announced positive headline results o.....»»

Category: personnelSource: nytJun 21st, 2018

BeyondSpring expects to announce Phase 3 interim data for Study 105 in Q4

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 21st, 2018

Fortress Biotech announces publication of CNDO-109-activated allogeneic NK data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 19th, 2018

Protagonist Therapeutics announces results from Phase 1 study of PTG-300

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 18th, 2018